Patent details

Basic Information

Publication number:

EP2155712

PCT Application Number:

PCT/US/2008/064374

Type:

European Patent Granted for LU

Legal Status:

Lapsed

Application number:

EP087560546

PCT Publication Number:

WO/2008/147815

First applicant's nationality:

Translation Language:

EPO Publication Language:

English

English Title of Invention:

3-(IMIDAZOLYL)-PYRAZOLOÖ3,4-BÜPYRIDINES

French Title of Invention:

3-(IMIDAZOLYL)-PYRAZOLOÖ3,4-BÜPYRIDINES

German Title of Invention:

3-(IMIDAZOLYL)PYRAZOLOÖ3,4-BÜPYRIDINE

SPC Number:

Dates

Filing date:

21/05/2008

Grant date:

07/09/2016

EP Publication Date:

07/09/2016

PCT Publication Date:

04/12/2008

Claims Translation Received Date:

Translations Received Date (B1 EP Publication):

Translations Received Date (B2 EP Publication):

Translations Received Date (B3 EP Publication):

Publication date:

24/02/2010

EP B1 Publication Date:

07/09/2016

EP B2 Publication Date:

EP B3 Publication Date:

Lapsed date:

21/05/2019

Expiration date:

21/05/2028

Renunciation date:

Revocation date:

Annulment date:

Owner

From:

21/05/2008

 

 

Name:

ChemoCentryx Inc.

Address:

850 Maude Avenue, Mountain View California 94043, United States (US)

Agent

Name:

OFFICE FREYLINGER S.A.

From:

09/11/2016

Address:

Boîte Postale 48, L-8001, STRASSEN, Luxembourg (LU)

To:

Inventor

1

Name:

PENNELL Andrew M. K.

Address:

United States (US)

2

Name:

LI Lianfa

Address:

United States (US)

3

Name:

ZHANG Penglie

Address:

United States (US)

Priority

Priority Number:

932948 P

Priority Date:

22/05/2007

Priority Country:

United States (US)

Classification

Main IPC Class:

C07D 401/00;

Annual Fees

Annual Fee Due Date:

Annual Fee Number:

Expected Payer:

Last Annual Fee Payment Date:

08/05/2018

Last Annual Fee Paid Number:

11

Last Annual Fee Paid Amount:

148 Euro

Payer:

MARKS & CLERK LLP

Filing date	Document type	Number of pages